Celltrion Group announced today results for its cocktail therapy candidates including neutralisation data against the Omicron variant (B.1.1.529). The Phase I clinical trial is a randomised, double- blind and placebo- controlled trial designed to evaluate the safety, tolerability and pharmacokinetics of CT-P63 in 24 healthy subjects in Poland.1 The study met its primary objectives with data showing CT-P63 to be safe and well tolerated, with no significant drug- related adverse events (AEs).
Cryogenic electron microscopy represents a revolutionary improvement in our ability to see biological molecules. Since its early development in the 70s it has become an important tool for understanding life at the tiniest scales.
Bioinformatics Market worth $21 8 billion by 2026 - Exclusive Report by MarketsandMarkets™ prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.